Form 4: Nexalin Technology CEO Awarded Stock Options
SEC Form 4 Filing
Mark White, President and CEO of Nexalin Technology, Inc., was granted stock options to purchase shares of common stock.
Summary
- Mark White, the President and CEO of Nexalin Technology, Inc., received stock options on February 26, 2025.
- He was granted options to purchase 447,427 shares at an exercise price of $0.894, vesting immediately, and expiring on June 30, 2033.
- Additionally, he received options to purchase 939,597 shares at an exercise price of $0.894, vesting in three equal annual installments based on performance criteria, and expiring on June 30, 2034.
- The performance criteria for the period ending June 30, 2024, were met, resulting in the vesting of options to purchase 313,199 shares.
- Following these transactions, White directly owns options to purchase a total of 1,387,024 shares.
Sentiment
Score: 7
Explanation: The sentiment is neutral to slightly positive. The granting of stock options is a common practice and the vesting based on performance is a positive sign. However, the impact on the company's financials is not immediately clear.
Positives
- The granting of stock options to the CEO aligns his interests with those of the shareholders.
- The vesting schedule based on performance criteria may incentivize the CEO to achieve company goals.
- The vesting of 313,199 shares indicates that performance targets were met for the period ending June 30, 2024.
Industry Context
Stock option grants are a common practice in the technology industry to incentivize executives and align their interests with shareholders. The size and vesting schedule of the grant are typical considerations.
Stakeholder Impact
- Shareholders may view the stock option grant as a positive incentive for the CEO.
- Employees may be motivated by the potential for company growth and success driven by the CEO's incentivized performance.
Key Dates
| Date | Description |
|---|---|
| 06/30/2024 | End of the first annual period for performance criteria related to option vesting; criteria were met for 313,199 shares. |
| 02/26/2025 | Date of the stock option grant to Mark White. |
| 02/27/2025 | Date of signature on the Form 4 filing. |
| 06/30/2033 | Expiration date for options to purchase 447,427 shares. |
| 06/30/2034 | Expiration date for options to purchase 939,597 shares. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.